Fidson Healthcare Plc: Quality products from WHO compliant factory to drive growth

In this audio, the Head of Account and Reporting, Fidson Healthcare Plc, Kunle Ajayi with Abayomi Obabolujo discussed extensively about the prospects in Fidson Healthcare. The following are worthy of note:

  • Volume growth from various products segment increased Company’s turnover in 2021 year end.
  • How Cost Optimization Programme reduced finance cost from over N2 billion to about N1bn
  • Government intervention funds in Healthcare space has been beneficial to Fidson
  • Increased dividend pay-out by 100% is a boost to investors’ confidence
  • Investment in infrastructure is aimed to ensure future growth
  • More products in pipeline from WHO compliant factory to guaranty growth in turnover

Leave a Reply

Your email address will not be published.

WP Twitter Auto Publish Powered By :